Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Revenue (2016 - 2025)

Historic Revenue for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$10.0 billion.

  • Sanofi's Revenue fell 24538.02% to -$10.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $60.4 billion, marking a year-over-year increase of 5061.03%. This contributed to the annual value of $49.3 billion for FY2025, which is 1088.15% up from last year.
  • Latest data reveals that Sanofi reported Revenue of -$10.0 billion as of Q4 2025, which was down 24538.02% from $37.8 billion recorded in Q3 2025.
  • Sanofi's Revenue's 5-year high stood at $46.3 billion during Q4 2023, with a 5-year trough of -$10.0 billion in Q4 2025.
  • Moreover, its 5-year median value for Revenue was $10.9 billion (2022), whereas its average is $13.6 billion.
  • As far as peak fluctuations go, Sanofi's Revenue surged by 91513.69% in 2021, and later crashed by 24538.02% in 2025.
  • Over the past 5 years, Sanofi's Revenue (Quarter) stood at $11.4 billion in 2021, then decreased by 4.29% to $10.9 billion in 2022, then soared by 323.51% to $46.3 billion in 2023, then crashed by 85.16% to $6.9 billion in 2024, then crashed by 245.38% to -$10.0 billion in 2025.
  • Its Revenue stands at -$10.0 billion for Q4 2025, versus $37.8 billion for Q3 2025 and $22.2 billion for Q2 2025.